معرفی
ABE Hiroyuki serves as a Lecturer at the Graduate School of Medicine, The University of Tokyo, specializing in Human Pathology with dual expertise in molecular oncology and forensic imaging. His work bridges cancer pathology and radiological sciences, focusing on Epstein-Barr virus mechanisms and postmortem diagnostic innovation.
His research portfolio spans:
- EBV-associated gastric cancer pathogenesis with emphasis on chromatin remodeling complexes (ARID1A) and miRNA dysregulation
- Development of autopsy imaging protocols for forensic radiology and cause-of-death determination
- AI-driven pathological analysis of gastrointestinal cancers using deep learning methodologies
- Integration of molecular pathology with radiological diagnostics for clinical and forensic applications
Dr. ABE directs multiple Japanese Grant-in-Aid projects including principal investigations into gastric cancer immune interactions (2018-2020) and AI pathology development (2023-2025), while co-leading pioneering work on postmortem CT diagnostics (2020-2028). His sustained funding since 2014 demonstrates significant research impact despite the absence of explicitly listed scientific awards in available records.
Current initiatives focus on establishing standardized autopsy imaging frameworks and machine learning systems for gastrointestinal cancer diagnosis, with upcoming projects extending through 2028 to refine hospital death diagnostics using advanced radiological techniques.
